Related by context. All words. (Click for frequent words.) 69 humanized antibody 67 Insegia 66 oral prodrug 65 CCR9 antagonist 64 AEG# 63 Factor VIIa 63 antibody MAb 63 recombinant subunit vaccine 63 PDE4 inhibitor 63 IMA# 63 PANVAC VF 62 Shigamabs ® 62 apricitabine ATC 62 Shigamabs R 62 Chimigen TM 62 HCD# [002] 62 metaglidasen 62 Panzem R NCD 62 anti CD3 monoclonal 62 epothilone 62 Thiovir 62 JAK1 62 torezolid 62 MKC# MT 61 HuMax CD4 61 MAXY alpha 61 gastro intestinal inflammation 61 OvaRex R 61 Exelixis compounds 61 R#/MEM # 61 bardoxolone 61 MyVax ® 61 MVA BN R 61 novel therapeutic antibodies 61 GPR# agonist 61 torezolid phosphate 61 Zenyaku Kogyo 61 Traficet EN 61 PRT# 61 vosaroxin 61 mertansine 61 KaloBios 61 YONDELIS 60 Nanobody 60 IAP inhibitors 60 nicotinic alpha 7 60 volociximab 60 OMP #M# 60 ONCONASE R 60 targeted radiotherapeutic 60 PGL# 60 INS# [001] 60 selective androgen receptor modulator 60 octreotide implant 60 HCV polymerase 60 Surfaxin LS 60 anti EGFR antibody 60 Allovectin 7 R 60 PRTX 60 VitiGam 60 recombinant polyclonal antibody 60 tiapamil 60 ELACYT 60 Allovectin 7 60 therapeutic monoclonal antibody 60 AVP #D# 60 Octreotide 60 ALN PCS 60 oncolytic virus therapies 60 atacicept 60 hepatitis C protease inhibitor 60 cancer immunotherapies 60 Neulasta R 60 Bicifadine 60 Onalta ™ 60 Alferon N 60 Hepatitis C Virus HCV 60 forodesine 60 Nanobody ® 59 HepaGam B 59 pradefovir 59 Symadex 59 PNP inhibitor 59 SinuNase ™ 59 Solasia 59 Amplimexon 59 Scancell 59 glucokinase activator 59 Veronate 59 EP #R 59 immunotherapeutic vaccine 59 NTDDS 59 A1PI 59 topical anti infective 59 ALN TTR# 59 zileuton CR 59 TRO# 59 IoGen 59 SCIB1 59 LHRH antagonist 59 ZFP Therapeutics 59 Granulocyte Colony Stimulating Factor 59 DPX Survivac 59 Solazed TM 59 JAK inhibitor 59 inhibit replication 59 Onalta 59 Panzem R 59 SNT MC# 59 selective immunoproteasome inhibitor 59 fusion inhibitor 59 Personalized Immunotherapy 59 flu mAb 59 Aflibercept 59 NXL# 59 CD# antibody [001] 59 BENLYSTA TM 59 Immunotherapeutic 59 NeuVax 59 tezampanel NGX# 59 HuLuc# 59 orally administered inhibitor 59 Micromet BiTE 59 AzaSite Plus 59 StaphVAX R 59 Phase 2a clinical trials 59 Telatinib 59 biologic therapeutics 59 investigational hepatitis B 59 selective S#P# receptor agonist 59 AnGes 59 TLR9 agonist 59 Aplidin 59 CORT # 59 omega interferon 59 SinuNase TM 59 IMiD 59 CytoFab 59 HuMax CD# 59 AGS PSCA 59 candidate deforolimus 59 HepeX B 59 CR# vcMMAE 59 incyclinide 59 IV Busulfex 59 XL# anticancer compounds 59 PF # [002] 59 OncoVEX 59 molecular imaging radiopharmaceutical 59 targeted antifolate 59 Aganocide 59 Archexin 59 recombinant biopharmaceutical 59 investigational monoclonal antibody 59 TKM ApoB 58 Zemiva TM 58 Maxy G# 58 ZADAXIN 58 Anavex #-# 58 KNS # 58 OMP #R# 58 TBC# 58 SAR# [002] 58 Prodarsan R 58 including eniluracil ADH 58 ALN TTR 58 Taligen 58 HuMax TAC 58 Azedra 58 MOVIPREP R 58 HIV integrase inhibitors 58 Luteinizing Hormone Releasing Hormone 58 Diamyd ® 58 Myocet 58 outlicensed 58 OHR/AVR# 58 soluble tumor necrosis 58 eniluracil 58 anti CD# monoclonal 58 RNAi therapeutic targeting 58 arsenic trioxide injection 58 Xyfid TM 58 Protexia R 58 CCX# 58 LymphoStat B TM 58 drug pipeline TAFA# 58 ZK EPO 58 Annamycin 58 CCR5 antagonist 58 ADP receptor antagonist 58 Firazyr 58 ASONEP TM 58 IMC #B 58 MAXY G# 58 Lixivaptan 58 XmAb ® 58 drug ISA# 58 synthetic retinoid 58 Cx# [002] 58 Vitaxin 58 therapeutic monoclonal antibodies 58 therapeutic peptide 58 UltiMAb 58 otelixizumab 58 L BLP# 58 CD# monoclonal antibody 58 NEUMUNE 58 Kyowa Kirin 58 OvaRex ® MAb 58 IND submission 58 CDP# 58 zanolimumab 58 telaprevir VX 58 alvespimycin 58 Civacir 58 luliconazole 58 successfully commercialize Iluvien 58 Tyzeka Sebivo 58 MorphoSys proprietary 58 elotuzumab 58 PEGylated interferon 58 AQ4N 58 VivaGel TM 58 registrational 58 RhuDex ® 58 Increlex TM 58 Phase IIb trials 58 ENMD # 58 R#/MEM 58 HQK 58 entinostat 58 pharmacological chaperone 58 Fodosine 58 ATL# [001] 58 Clolar ® 58 tramiprosate Alzhemed TM 58 rxRNA 58 TLK# 57 pexiganan 57 BCR ABL inhibitors 57 immatics 57 Preotact R 57 HspE7 57 JAK inhibitors 57 receptor tyrosine kinase inhibitor 57 candidate TNFerade biologic 57 CD# CEA 57 DOS# 57 Oncaspar 57 romidepsin novel 57 Xcytrin R 57 outlicensing 57 OncoGel 57 Theratope 57 valopicitabine 57 XmAb# 57 liposomal formulation 57 Spiegelmer ® 57 dextromethorphan quinidine 57 pafuramidine 57 reslizumab 57 SAR# [004] 57 sitaxsentan 57 nucleotide analog 57 HIV integrase inhibitor 57 humanized monoclonal antibody 57 Bioral Amphotericin B 57 vinorelbine tartrate 57 Protexia ® 57 THR beta agonist 57 Ecallantide 57 Androxal TM 57 GRN# 57 Neo Kidney Augment ™ 57 HSP# inhibitor 57 BioNumerik 57 JAK2 inhibitor 57 Fc fusion protein 57 NicVAX 57 monoclonal 57 Loramyc 57 Triapine 57 LymphoStat B belimumab 57 valtorcitabine 57 ESTRASORB 57 XmAb 57 obatoclax 57 VaxImmune 57 TKB# 57 ATL# [002] 57 cannabinor 57 Urocidin TM 57 Zorbtive TM 57 candidate REP# 57 bremelanotide 57 MAXY VII 57 GED aPC 57 sodium glucose transporter 57 GLP toxicology studies 57 TPI ASM8 57 Loramyc ™ 57 prostone 57 Tyrima 57 Relivar 57 HepaGam B R 57 XL# XL# 57 celgosivir 57 siRNA therapeutics 57 MCSP respectively 57 PXD# 57 RECOTHROM ® 57 CEQ# 57 Tumour Vascular Disrupting Agent 57 ARIKACE ™ 57 Troxatyl 57 Kosan dependence 57 relapsed leukemia 57 Cathepsin S 57 FOLOTYN ® 57 Eligard ® 57 MSCRAMM 57 MGd 57 vidofludimus 57 Aurexis 57 Symbollon 57 generation PNP inhibitor 57 teplizumab 57 lintuzumab SGN 57 leading oral taxane 57 oral picoplatin 57 TRISENOX ® 57 formerly LymphoStat B 57 romazarit 57 thymalfasin 57 novel L DOS# 57 candidate CRLX# 57 dasatinib Sprycel 57 PNT# 57 Epratuzumab 57 inflammatory autoimmune diseases 57 Ascend Therapeutics 57 RNAi therapeutic 57 Evoltra ® 57 Solazed 57 DermaVir Patch 57 Preotact 57 integrase inhibitor 57 RECOTHROM R 57 triphendiol 57 Uvidem 57 PrevOnco 57 Onconase 57 IND enabling 57 cGMP manufacture 56 Prodarsan ® 56 personalized immunotherapy 56 Stimuvax R 56 dextofisopam 56 Zalbin 56 faropenem 56 Neulasta ® 56 Tolerx 56 ularitide 56 MKC# MKC# PP 56 GVAX cancer 56 tubulin inhibitor 56 chemotherapy induced neutropenia 56 Proxinium TM 56 thrombopoietin 56 Ziopharm 56 glatiramer 56 Octreolin 56 URG# 56 accumulate preferentially 56 PentaStaph 56 Cetrorelix 56 Azedra TM 56 Unit Dose Budesonide 56 novel histone deacetylase 56 Sopherion 56 DiaPep# 56 Azilect ® 56 MGCD# [001] 56 SYCREST 56 Alzhemed TM 56 sodium glucose cotransporter 56 Homspera 56 PREOS R 56 Lovaza TM 56 chimeric monoclonal antibody 56 Sym# 56 OncoVEX GM CSF 56 TKM PLK1 56 HuCAL antibodies 56 MAb therapy 56 Vaccinex 56 Plicera 56 Albugon 56 diarrhea predominant irritable 56 elvucitabine 56 virus HCV protease inhibitor 56 Gentamicin Surgical Implant 56 Argatroban 56 Fentanyl Taifun 56 Rhucin ® recombinant 56 oral antiviral 56 Novosom 56 SYGNIS 56 Ambrx 56 Delafloxacin 56 Selective Electrochemical Tumor Ablation 56 alemtuzumab Campath 56 intranasal formulation 56 dacetuzumab 56 oncolytic 56 TRAIL receptor antibodies 56 acetonide FA 56 EVIZON TM squalamine lactate 56 LGLS 56 Intarcia 56 SUMAVEL 56 drug conjugate 56 Increlex R 56 Tesetaxel 56 PSN# [002] 56 PEG interferon 56 Somatuline Depot 56 VALSTAR 56 XL# XL# XL# XL# 56 INCB# [001] 56 Nanobody R 56 Lupuzor 56 Pimavanserin 56 VitiGam TM 56 PEG SN# 56 Urokinase 56 cetuximab Erbitux R 56 Preclinical studies suggest 56 midstage clinical 56 RNAi therapeutic targeting PCSK9 56 apaziquone 56 HepaLife 56 danoprevir 56 depsipeptide 56 Vilazodone 56 forodesine hydrochloride 56 Xanafide 56 TetraLogic 56 nucleoside tide 56 RNA antagonists 56 MAGE A3 ASCI 56 rolapitant 56 panitumumab Vectibix 56 oral taxane 56 immunotherapeutic approaches 56 phase IIa clinical 56 therapeutic antibody 56 SILENOR 56 defensin mimetic antibiotic 56 Loramyc R 56 Adnectin 56 immunotherapeutics 56 Captisol enabled 56 anti CD# antibodies 56 CYT# potent vascular disrupting 56 Valortim TM 56 Davanat 56 InterfeRx 56 Angiocept 56 JAK3 56 Behcet uveitis 56 CMV vaccine 56 SPL# Gel vaginal microbicide 56 orally bioavailable mimics 56 biosurgical 56 G#DT 56 PDX pralatrexate 56 anticancer therapeutics 56 TaiGen 56 budesonide foam 56 nanoviricides 56 anti CD# antibody 56 Pancreate 56 lumiliximab 56 IMPDH inhibitor 56 Phase IIb clinical trials 56 Viventia 56 rasagiline tablets 56 biased ligand 56 Azixa 56 Innovive Pharmaceuticals 56 Curaxin 56 Glassia 56 deforolimus 56 cathepsin K inhibitor 56 ASONEP 56 PDE# inhibitors 56 Leukine ® 56 ProMune 56 Omigard 56 Bezielle 56 Vegenics 56 antisense drug 56 systemic RNAi 56 ceftazidime 56 generation purine nucleoside 56 Cumulase 56 Zenvia ™ 56 MAb 55 Lumacan 55 solithromycin 55 recombinant factor VIIa 55 LNP formulations 55 factor VIIa 55 Panzem 55 hepatitis C HCV 55 SERMs 55 Syntonix 55 trabectedin 55 COPEGUS R 55 targeting PCSK9 55 Alnylam #x# 55 Cellegesic 55 Endotis 55 XP# XP# 55 Stapled Peptide 55 ITAX 55 proteasome inhibitor 55 ATryn ® 55 Cintredekin Besudotox 55 GW# [003] 55 EpiCeram 55 TG# [003] 55 SARMs 55 lenalidomide Revlimid R 55 candidate epratuzumab 55 immunotoxin 55 Olaparib 55 GLPG# 55 isoform selective 55 Anticalins 55 Amigal 55 neuroprotective properties 55 ALN HPN 55 Peptimmune 55 Copegus ribavirin 55 Soliris TM eculizumab 55 Polymer Microspheres 55 GeoVax vaccine 55 Somatuline R Autogel R 55 MEK inhibitors 55 BrachySil ™ 55 Exherin 55 AeroLEF R 55 recombinant plasma 55 BiTE 55 HCV protease inhibitor 55 ceftaroline 55 OMJPI 55 Zenapax 55 Onco TCS 55 registrational trial 55 rhFVIIa 55 ALN VSP 55 Trofex 55 Solazed ™ 55 BrachySil TM 55 beta 1a 55 ChronVac C R 55 Numax 55 MONOVISC 55 polymerase inhibitor 55 HGS# 55 Cytochroma 55 Amgen Neulasta R 55 Hybridon 55 registrational trials 55 Dicer Substrate Technology 55 tanespimycin 55 EGRIFTA TM 55 Dapagliflozin 55 vaccines oncolytic virus 55 SIRT1 activators 55 Viramidine 55 oral PTH 55 HGS ETR1 55 XOMA 3AB 55 recombinant antibodies 55 sargramostim 55 GAP #B# 55 OGeS 55 Plenaxis R 55 ulimorelin 55 replicon 55 enzastaurin 55 Tavocept 55 TACI Ig 55 AzaSite TM 55 B lymphocyte stimulator 55 targeting CD# 55 BEMA TM Fentanyl 55 RhuDex TM 55 Squalamine 55 Ophthotech 55 Trofex TM 55 Aerosurf 55 PEGylated Fab fragment 55 Fresenius Biotech 55 inhaled AAT 55 Prestara 55 YONDELIS R 55 sumatriptan DosePro 55 Epothilones 55 Alfacell proprietary ribonuclease 55 ovarian cancer chronic hepatitis 55 IV APAP 55 Marqibo TM 55 methylnaltrexone 55 Nabi HB 55 phase IIb clinical 55 ZEVALIN ® 55 potent antiproliferative 55 polymer platinate 55 ABILIFY ® 55 ATG Fresenius S 55 urocortin 2 55 CD3 monoclonal antibody 55 HCV protease inhibitors 55 Celator 55 small molecule tyrosine 55 treat dysmenorrhea 55 droxidopa 55 rhMBL 55 Anticalins R 55 platinum chemotherapeutic 55 CINOD 55 ospemifene 55 Apoptone 55 ART# 55 adrenergic regulation 55 Generx TM 55 BRAF V#E mutation 55 Toraymyxin TM 55 MYDICAR ® 55 Loramyc TM 55 maribavir 55 T#I [002] 55 HuCAL R 55 Iluvien ® 55 Cutanea 55 Filgrastim 55 UVIDEM 55 Somatuline R Depot 55 UPLYSO 55 tamibarotene 55 PHX# 55 histone deacetylase HDAC inhibitor 55 Lexiscan ® 55 PDL# 55 HCV polymerase inhibitors 55 adenoviral 55 Telintra 55 immune modulating 55 IMC #F# 55 Prednisporin 55 selective GR 55 MDV# 55 Frova ® 55 HyACT 55 preclinical 55 inhaled liposomal ciprofloxacin 55 CAMPATH 55 stated Michelle Berrey 55 tramiprosate ALZHEMED TM 55 BHT DNA 55 Vascular Wrap TM 55 AzaSite Xtra 55 cardio renal 55 phase IIb trial 55 delta opioid receptor 55 AMPK activators 55 DXL# 55 epigenetic therapies 55 systemic RNAi therapeutic 55 goserelin 55 Presents Preclinical 55 non nucleoside inhibitor 55 Tarvacin 55 PROGENSA R 55 KSP inhibitor 55 Itero 55 Æterna Zentaris 55 MEK inhibitor 55 daptomycin 55 P#X# antagonist 55 generation calcineurin inhibitor 55 Fc engineered 54 RELISTOR ® 54 Adenosine Therapeutics 54 Janssen Pharmaceutica NV 54 Firazyr ® 54 Cerimon 54 E1 INT TM 54 AVONEX ® 54 oral ghrelin agonist 54 RELOVAIR ™ 54 small molecule glucokinase 54 HEPLISAV ™ 54 commercialize DAVANAT ® 54 highly selective endothelin 54 aerosolized AAT 54 Fortical R 54 Virulizin ® 54 TRIOLEX ™ 54 StemEx 54 Micromet proprietary BiTE 54 delta isoform 54 cartilage regeneration 54 antisense inhibitors 54 tolevamer 54 Acute Radiation Syndrome ARS 54 bilastine 54 non nucleoside HCV 54 HCV polymerase inhibitor 54 AdVac 54 Phase #b/#a clinical 54 fluoropyrimidine 54 DCCR 54 Ceflatonin R 54 REBETOL combination therapy 54 Clavis Pharma 54 cMET inhibitor 54 EndoTAG 54 Actimmune ® 54 WILEX 54 immunotherapeutic 54 vaginally administered lidocaine 54 HyperAcute 54 Novolimus 54 ARG# 54 QRxPharma 54 Syncria 54 include Healive 54 BLA filing 54 crofelemer 54 autoimmune indications 54 Alvesco R 54 Zelrix 54 Helsinn 54 oral ridaforolimus 54 DPP4 inhibitor 54 JAK2 inhibitors 54 Sphingomab 54 Thrombin 54 Posiphen TM 54 Ocrelizumab 54 NV1FGF 54 Vicriviroc 54 treats acute lymphoblastic 54 tivozanib AV 54 Potelligent Technology 54 unpartnered 54 COLAZAL R 54 Epitomics 54 Fibrillex TM 54 novel antiviral therapeutics 54 orally bioavailable 54 Xcellerated T Cells 54 valopicitabine NM# 54 AE# vaccine 54 PER.C6 ® cell 54 midstage studies 54 midkine 54 elinogrel 54 preclinical compounds 54 CCR2 54 ara C 54 sterile lidocaine patch 54 Mestinon 54 developing TB4 54 siRNAs targeting 54 Icatibant 54 POSIDUR TM ELADUR TM 54 Aganocide ® 54 Omigard TM 54 Eligard R 54 Femprox ® 54 Proellex TM 54 Transave 54 pathophysiological effects 54 TYZEKA 54 ASG 5ME 54 ocrelizumab 54 Nautilus Biotech 54 Nektar PEGylation technology 54 tranilast 54 Cytolin R 54 ganetespib 54 Guanilib 54 chemopreventive agent 54 Cethromycin 54 LUCASSIN 54 OXi# 54 Tostrex 54 Oasmia 54 treat male hypogonadism 54 anticancer compounds 54 PORxin TM 54 TRX1 54 Daclizumab 54 MAbs 54 PLK1 SNALP 54 PN# [001] 54 Opterone R 54 highly selective adenosine 54 histone deacetylase HDAC inhibitors 54 IMiDs ® 54 custirsen 54 Alnylam RNAi 54 novel peptides 54 radiotherapeutic 54 castrate resistant prostate cancer 54 hypoxia activated prodrug 54 Alocrest 54 Raptiva R 54 Cenomed 54 QuatRx 54 anticancer compound 54 clivatuzumab 54 Mersana 54 Urocidin 54 TRAIL Receptor 54 platforms GVAX 54 Allovectin 7 r 54 preclinical toxicology 54 ImmunoGen TAP technology 54 RLY# 54 Janus kinase 54 SynCon 54 hyperimmune products 54 NurOwn 54 ALN RSV program 54 RTP #i 54 NovaBay Aganocide compounds 54 commercialize becocalcidiol patented 54 orthobiologic 54 oral proteasome inhibitor 54 micafungin 54 belinostat 54 Uracyst ® 54 IgG1 antibody 54 EOquin 54 p# inhibitor 54 sirtuin modulators 54 Shigamabs 54 AdnaGen 54 DAVANAT R 54 Rotarix R 54 OncoMed 54 systemic immunosuppressive drugs 54 PharmaNova 54 Elvitegravir 54 INCB# [002] 54 RenaZorb 54 candidate Ramoplanin 54 farletuzumab 54 QuantRx 54 forodesine hydrochloride BCX 54 SARcode 54 rThrombin 54 Onalta TM 54 Targeted Chemotherapy 54 VEGF Trap 54 PhaseBio 54 preclinically 54 Corgentin 54 allosteric modulator 54 NNRTIs 54 Prednisporin TM 54 AVN# [001] 54 Regado 54 TLR8 agonist 54 SuperAntibody 54 HCV nucleoside polymerase inhibitors 54 AmpliMed 54 PERLANE 53 outlicense 53 HuMax 53 personalized dendritic 53 INTEGRILIN R eptifibatide Injection 53 Inflazyme 53 mAb 53 pafuramidine maleate 53 Cleviprex TM clevidipine 53 TOCOSOL Paclitaxel 53 cat dander allergy 53 BEXXAR 53 BCX# 53 motexafin gadolinium Injection 53 lomitapide 53 MyVax 53 ATL/TV# 53 product Fentanyl TAIFUN 53 pegylated interferon alpha 53 Phase #b/#a 53 Nanobodies 53 TH# [003] 53 Synavive 53 REGiMMUNE 53 Catena ® 53 Reverset 53 ALTROPANE R 53 MORAb 53 elbion 53 Generx ™ 53 Liprostin 53 ViroChem 53 Intravenous CP 53 Rescula 53 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 53 Biolipox 53 generation NEUGENE 53 Phase IIa clinical trials 53 DURIN TM 53 opioid bowel dysfunction 53 CDK inhibitor 53 UltiMAb ® 53 Ketotransdel 53 Cethrin R 53 Captisol ® 53 Alexza Staccato 53 LB# [003] 53 Factor VEGF 53 DEB# 53 CB2 selective 53 Virium 53 DsiRNA 53 ProLindac TM 53 Nicholas Nicolaides 53 Omacetaxine 53 mGluR2 NAM 53 Neo Kidney Augment 53 EpiCept NP 1 53 pomalidomide 53 Optiquel ™ 53 FACTIVE R gemifloxacin 53 DepoDur 53 Elisabeth Lindner CEO 53 Nasdaq HALO biopharmaceutical 53 Blinatumomab 53 candidate Zenvia 53 Talabostat 53 Zolinza 53 Celacade TM 53 RGB # 53 Anacor 53 Prism Pharmaceuticals 53 Zemiva TM Trofex TM 53 DNA methylation biomarkers 53 Canvaxin TM 53 SEPET TM 53 Collategene 53 Phase IIa trials 53 immunological diseases 53 polymerase inhibitors 53 immune modulators 53 ddRNAi 53 DDP# 53 novel antibody therapeutics 53 5 HT6 53 maturation inhibition 53 Cerashield ™ 53 Thrombin topical Recombinant 53 HuMax HepC TM 53 Dextofisopam 53 Anticalin 53 PrevOnco ™ 53 GFT# 53 Orphan Drug designations 53 virosome 53 humanized antibodies 53 Flutiform TM 53 midstage trials 53 IDRI 53 pan HDAC inhibitor 53 Aggrastat 53 ostarine 53 Polyphenon ® E 53 neurokinin 1 53 PSMA ADC 53 Neurimmune 53 bicifadine 53 fipamezole 53 Phase 2b clinical trials 53 Novartis NVS Snapshot Report 53 HCl Tablets 53 Affilin ® 53 NOXXON 53 Symphogen